Anti-p53 antibody [PAb 240]
- KO Validated
- Lab Essentials
- What is this?
4
(56 Reviews)
|
(530 Publications)
Anti-p53 antibody [PAb 240] (ab26) is a mouse monoclonal antibody detecting p53 in Western Blot, IP, ICC/IF. Suitable for Human, Mouse.
- KO validated for confirmed specificity
- Over 400 publications
- Trusted since 1998
View Alternative Names
P53, Trp53, Tp53, Cellular tumor antigen p53, Tumor suppressor p53
- WB
Supplier Data
Western blot - Anti-p53 antibody [PAb 240] (AB26)
Lanes 1-6 : Merged (red and green) signal.
ab26 was shown to specifically react with p53 in wild type HCT116 cells treated with irinotecan. No band was observed in p53 knockout HCT116 cells. Wild-type and p53 knockout samples, positive and negative controls were subjected to SDS-PAGE. ab26 and ab181602 (loading control to GAPDH) were diluted 5 μg/mL and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with goat anti-rabbit IgG (H + L) and goat anti-mouse IgG (H + L) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.
Wild-type and p53 knockout HCT116 cell lysates were kindly provided by a collaborator.
All lanes:
Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL
Lane 1:
Wild-type HCT116 cell lysate at 30 µg
Lane 2:
Wild-type HCT116 + irinotecan (10 µM, 24 hours) cell lysate at 30 µg
Lane 3:
p53 knockout HCT116 cell lysate at 30 µg
Lane 4:
p53 knockout HCT116 + irinotecan (10 µM, 24 hours) cell lysate at 30 µg
Lane 5:
A431 cell lysate (positive control) at 20 µg
Lane 6:
Saos-2 cell lysate (negative control) at 20 µg
Predicted band size: 43 kDa
Observed band size: 53 kDa
false
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-p53 antibody [PAb 240] (AB26)
ab26 stained in A431 cells. Cells were fixed with 4% paraformaldehyde (10min) at room temperature and incubated with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% triton for 1h at room temperature to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with ab26 at 1μg/ml and ab6046 (Rabbit polyclonal to beta tubulin) at 1ug/ml overnight at +4°C. The secondary antibodies were ab150177 (colored green) used at 1 ug/ml and ab150087 (pseudo-colored red) used at 2ug/ml for 1hour at room temperature. DAPI was used to stain the cell nuclei (colored blue) at a concentration of 1.43μM for 1hour at room temperature.
- IP
AbReview41852****
Immunoprecipitation - Anti-p53 antibody [PAb 240] (AB26)
p53 was immunoprecipitated from 7x106 HCT116 (human colon carcinoma cell line) cells with ab26 at 1/150 dilution. Western blot was performed from the immunoprecipitate using anti-p53 antibody. Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed (ab175739) was used as secondary antibody at 1/5000 dilution.
Lane 1 : HCT116 whole cell lysate 10 μg (Input).
Lane 2 : ab207799 IP in etoposide treated HCT116 whole cell lysate.
Lane 3 : ab207799 IP in etoposide treated HCT116 p53-/- whole cell lysate (negative control).
All lanes:
Anti p53 antibody
Secondary
All lanes:
Immunoprecipitation - Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed (<a href='/en-us/products/secondary-antibodies/donkey-mouse-igg-h-l-alexa-fluor-750-preadsorbed-ab175739'>ab175739</a>) at 1/5000 dilution
Predicted band size: 43 kDa
false
- WB
Project
Western blot - Anti-p53 antibody [PAb 240] (AB26)
All lanes:
Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL
Lane 1:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg
Lane 2:
Hela Whole Cell Lysate - Bleomycin Treated (40U/ml) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/5000 dilution
Predicted band size: 43 kDa
true
Exposure time: 4min
- WB
Lab
Western blot - Anti-p53 antibody [PAb 240] (AB26)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab26 overnight at 4°C. Antibody binding was detected using an anti-mouse HRP secondary antibody (ab97040), and visualised using ECL development solution ab133406.
All lanes:
Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1 µg/mL
All lanes:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/50000 dilution
Predicted band size: 43 kDa
Observed band size: 53 kDa
true
Exposure time: 8min
- WB
AbReview11453****
Western blot - Anti-p53 antibody [PAb 240] (AB26)
All lanes:
Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1/2000 dilution
Lane 1:
Human breast cancer cell-line, MCF7 cells (p53 WT), whole cell lysate at 20 µg
Lane 2:
Human breast cancer cell-line, MDA231 cells (p53 Mutant), whole cell lysate at 20 µg
Secondary
All lanes:
HRP conjugated donkey anti-mouse antibody at 1/5000 dilution
Predicted band size: 43 kDa
Observed band size: 53 kDa,72 kDa
true
Exposure time: 10s
This image is courtesy of an Abreview submitted by Dr Cherie Blenkiron
- WB
Lab
Western blot - Anti-p53 antibody [PAb 240] (AB26)
Lanes 1-2 : 1% BSA blocking buffer
Lanes 3-4 : 3% Milk blocking buffer
We recommend using 3% milk as the blocking agent for Western blot.
Lanes 1 - 2:
Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1 µg/mL
Lanes 3 - 4:
Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL
All lanes:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg
Secondary
All lanes:
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution
Predicted band size: 43 kDa
true
Exposure time: 4min
- WB
Unknown
Western blot - Anti-p53 antibody [PAb 240] (AB26)
Primary : All Lanes : Anti-p53 antibody (ab26) at 5 μg/mL. Lane 1 : MW marker. Lane 2 : NIH/3T3 cells treated with vehicle for 24 hours. Lane 3 : NIH/3T3 cells treated with 1 μM doxorubicin for 24 hours Secondary : All Lanes : HRP-conjugated VeriBlot anti-Mouse IgG (ab131368) 1 : 1000. Lysates at 20 μg/lane. Performed under denaturing conditions. Developed using ECL technique. Blocking buffer : 5% milk in PBS.
All lanes:
Western blot - Anti-p53 antibody [PAb 240] (ab26)
Predicted band size: 43 kDa
false
- WB
CiteAb
Western blot - Anti-p53 antibody [PAb 240] (AB26)
Western Blotting using Anti-p53 antibody [PAb 240], ab26. Publication image from Zhang, P. et al., 2020, J Biomed Sci, 32005234. Legend direct from paper.
SERPINB5 is indispensable for TRIM21-mediated GMPS–TP53 repression after radiation. a Co-immunoprecipitation following western blotting in NPC cells with SERPINB5–HA and TRIM21–MYC overexpression. b Immunofluorescence staining analysis of SERPINB5 and TRIM21 in NPC cells. c Western blot detection of SERPINB5 expression in normal NP69 cell line and in NPC cell lines. d Western blot detection of GMPS and TP53 in NPC cells with TRIM21 GOF or SERPINB5 LOF. e Co-immunoprecipitation using anti-HA antibody in NPC cells with SERPINB5–HA and GMPS–FLAG overexpression. f Immunofluorescence staining to detect the co-localization of GMPS and SERPINB5 in NPC cells with or without ionizing radiation. g GMPS expression in immune-purified protein by anti-HA antibody from NPC cells with or without TRIM21 LOF. h GMPS expression in immune-purified protein by anti-MYC antibody from NPC cells with or without SERPINB5 LOF. i GMPS expression in NPC cells with TRIM21 or SERPINB5 overexpression. j Immunofluorescence staining of overexpressed GMPS and ubiquitin in HONE1 cells with or without ionizing radiation. The localization of GMPS and was evaluated in condition of SERPINB5 or TRIM21 LOF. For the co-immunoprecipitation assay, MG132 was added into the cell medium before cell harvesting to avoid GMPS degradation. *P < 0.05, **P < 0.01, ***P < 0.001
false
- WB
CiteAb
Western blot - Anti-p53 antibody [PAb 240] (AB26)
Western Blotting using Anti-p53 antibody [PAb 240], ab26. Publication image from Zhang, P. et al., 2020, J Biomed Sci, 32005234. Legend direct from paper.
TRIM21 protects NPC cells from radiation-induced apoptosis by manipulating the GMPS–TP53 cascade. a Western blot detection of TP53 expression in HONE1 cells after radiation. b Co-immunoprecipitation using anti-FLAG antibody following western blot detection of USP7 and TP53 expression in GMPS–FLAG-overexpressing NPC cells with or without X-ray radiation. c GMPS expression in TRIM21-overexpressing NPC cells with or without X-ray radiation. d Co-immunoprecipitation using anti-MYC antibody following western blot detection of GMPS expression in TRIM21–MYC-overexpressing NPC cells with or without X-ray radiation. e Flow cytometry analysis of Annexin V and PI staining in HONE1 cells with TRIM21 GOF or LOF after X-ray radiation. Annexin+PI− cells, which were in the early apoptotic stage, were evaluated and quantified. f, g Quantification of the apoptotic HONE1 f and 5-8F g cells. h, i Clonogenic survival assay of HONE1 cells with TRIM21 GOF h or LOF i. j Absorbance intensity of TRIM21 GOF and LOF tumor cells and their counterpart controls in mice (n = 5 for each group). The tumors were evaluated 2 and 3 weeks, respectively, after implantation, and the mice received radiotherapy (2 Gy daily and a total of 12 Gy) after 2 weeks. k, l The absorbance intensity analysis of tumors in mice. For the co-immunoprecipitation assay, the cells were pre-treated with MG132 to avoid GMPS degradation before harvesting. *P < 0.05, **P < 0.01, ***P < 0.001. Mu, mutant; ns, not significant; IP, immunoprecipitation
false
- WB
CiteAb
Western blot - Anti-p53 antibody [PAb 240] (AB26)
Western Blotting using Anti-p53 antibody [PAb 240], ab26. Publication image from Zhang, T. et al., 2022, Nat Commun, 36376321. Legend direct from paper.
Kmt5b prevents replication stress and genome instability in proliferating MuSC.a Proliferation rate of Ctrl (n = 3 mice) and Kmt5bsKO (n = 4 mice) MuSCs quantified during time lapse imaging. Confluency of Ctrl and Kmt5bsKO MuSCs at the last time point is on the right. b Immunofluorescence staining for EdU and γH2AX in Ctrl and Kmt5bsKO MuSCs after 4 days in culture (n = 4 mice). DNA was stained by DAPI. Scale bar : 10 µm. Median of fluorescence intensity (MFI, arbitrary units (arb. units)) of γH2AX/EdU+ and γH2AX/EdU− MuSCs are shown on the right. Data are shown as mean ± SEM; Two-way ANOVA. c Representative images of DNA fibers labeled with CIdU and IdU. Scale bar : 10 µm. Quantification of fork progression in Ctrl and Kmt5bsKO MuSCs is shown on the right (n = 3 mice). Data are shown as mean ± SEM; Two-way. d Percentage of stalled folks in Ctrl and Kmt5bsKO MuSCs in all fibers (n = 3 mice). e Images of DAPI-stained metaphase chromosome spreadings prepared from Ctrl and Kmt5bsKO MuSCs (n = 3 mice). Scale bar : 10 µm. Quantification of aneuploid MuSCs is on the right. f Immunofluorescence staining forα-tubulin/DAPI showing Kmt5bsKO MuSCs with micronuclei (indicated by arrowheads). Scale bar : 10 µm. Percentage of Ctrl (n = 3 mice) or Kmt5bsKO (n = 4 mice) MuSCs with micronuclei is on the right. g Western blot analysis of pP53 and γH2AX in Ctrl and Kmt5bsKO MuSCs after 4 days in culture. Pan-Actin was used as loading control. Band intensities were quantified, corresponding plots are shown on the right (n = 3 mice). h RT-qPCR analyses of p21 expression in Ctrl and Kmt5bsKO MuSCs (n = 3 mice). 36b4 was used as reference gene. i SA-β-GAL staining of Ctrl and Kmt5bsKO MuSCs after 7-days in proliferation medium (n = 3 mice). Scale bar : 20 µm. Quantification of SA-β-GAL positive cells is on the right. Data are shown as mean ± SEM. Unpaired two-sided Student’s t-tests were employed for all panels except for (b) and (c). Source data are provided in the Source Data file.
false
Related conjugates and formulations (1)
-
Anti-p53 antibody [PAb 240] - BSA and Azide free
Reactivity data
Product details
ab26 has been knockout validated in Western blot. The expected band was seen in wild type HCT116 cells treated with the DNA damaging agent irinotecan and no band was seen in TP53 knockout HCT116 cells.
Product Specifications
Anti-p53 antibody [PAb 240] (ab26) is a mouse monoclonal antibody and is validated for use in ICC/IF, IP, WB in human, mouse samples.
Anti-p53 antibody [PAb 240] (ab26) specifically detects p53 (UniProt ID: P04637; Molecular weight: 44kDa) and is sold in 100 µg selling sizes.
Quality and Validation
Abcam's high quality validation processes ensure Anti-p53 antibody [PAb 240] (ab26) has high sensitivity and specificity.
The specificity of Anti-p53 antibody [PAb 240] (ab26) has been confirmed by testing in knockout samples.
Anti-p53 antibody [PAb 240] (ab26) has been cited over 403 times in peer reviewed journals and is trusted by the scientific community.
Anti-p53 antibody [PAb 240] (ab26) has 54 independent reviews from customers.
Related Products
Conjugation-ready, carrier free format available for antibody clone PAb 240 - ab185238.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.
Pathways
P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (530)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:710 PubMed41057318
2025
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 20:e0332761 PubMed41060973
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:8726 PubMed41028714
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 72:229-241 PubMed40958520
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 21:5476-5495 PubMed40959275
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 23:575 PubMed40830790
2025
Applications
Unspecified application
Species
Unspecified reactive species
Open life sciences 20:20251151 PubMed40822973
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 56: PubMed40641112
2025
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 10:212 PubMed40624014
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 52:541-563 PubMed40599343
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com